Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin https://pubmed.ncbi.nlm.nih.gov/21193398/

Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma https://www.nature.com/articles/s41419-019-1989-z

Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor Efficacy https://cancerimmunolres.aacrjournals.org/content/8/7/952